(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
5 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 0.00%
2.26% SEK 29.40
Live Chart Being Loaded With Signals
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments...
Stats | |
---|---|
Volumen de hoy | 219 728 |
Volumen promedio | 422 520 |
Capitalización de mercado | 14.98B |
EPS | SEK0 ( 2024-02-15 ) |
Próxima fecha de ganancias | ( SEK0.330 ) 2024-05-02 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | 133.64 |
ATR14 | SEK0.0970 (0.33%) |
Volumen Correlación
Vimian Group AB (publ) Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Vimian Group AB (publ) Correlación - Moneda/Commodity
Vimian Group AB (publ) Finanzas
Annual | 2023 |
Ingresos: | SEK331.73M |
Beneficio Bruto: | SEK229.43M (69.16 %) |
EPS: | SEK0.0194 |
FY | 2023 |
Ingresos: | SEK331.73M |
Beneficio Bruto: | SEK229.43M (69.16 %) |
EPS: | SEK0.0194 |
FY | 2022 |
Ingresos: | SEK281.31M |
Beneficio Bruto: | SEK193.99M (68.96 %) |
EPS: | SEK-0.0179 |
FY | 2021 |
Ingresos: | SEK173.35M |
Beneficio Bruto: | SEK80.31M (46.33 %) |
EPS: | SEK0.0200 |
Financial Reports:
No articles found.
Vimian Group AB (publ)
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. The company was incorporated in 2020 and is headquartered in Stockholm, Sweden.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico